<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33506486</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>03</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1576-6578</ISSN><JournalIssue CitedMedium="Internet"><Volume>72</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>Revista de neurologia</Title><ISOAbbreviation>Rev Neurol</ISOAbbreviation></Journal><ArticleTitle>[Vulpian-Bernhardt syndrome. Its frequency and clinical and electrophysiological features in a tertiary care centre in Mexico].</ArticleTitle><Pagination><StartPage>85</StartPage><EndPage>91</EndPage><MedlinePgn>85-91</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.33588/rn.7203.2020126</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Vulpian-Bernhardt syndrome (VBS) is an atypical rare clinical phenotype of amyotrophic lateral sclerosis (ALS) that causes a significant delay in diagnosis, and thus it is important to recognise its clinical and electrophysiological features.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Retrospective cross-sectional study. We reviewed the clinical records of patients diagnosed with ALS in the period from January to December 2019. Those meeting criteria for VBS were included so as to describe their frequency as well as their clinical and electrophysiological features.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty patients (15.8%) met criteria for VBS; 55% were female; age at onset of symptoms was 46.6 &#xb1; 12.9 years; 40% were smokers; median delay in diagnosis was 24 (12-96) months; median time to involvement of the second body segment was 24 (12-132) months, which was lumbosacral in 65%; mean Revised Amyotrophic Lateral Sclerosis Functional Rating Scale score was 27 &#xb1; 7 points; 45% met the El Escorial criteria for ALS defined at diagnosis and 58.8% met the Awaji criteria. There were 19 nerve conduction studies and 17 electromyograms, and an abductor digiti minimi-abductor pollicis brevis (ADM/APB) ratio &lt; 0.6 was found in 63% (split hand).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">There is a significant delay in the diagnosis of motor neuron diseases in general and more particularly in VBS. Calculating the ADM/APB ratio and applying the Awaji criteria in the electrophysiology study can be a valuable aid to increase diagnostic certainty in this clinical entity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>L&#xf3;pez-Hern&#xe1;ndez</LastName><ForeName>J C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Neurolog&#xed;a y Neurocirug&#xed;a Dr. Manuel Velasco Su&#xe1;rez, Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baz&#xe1;n-Rodr&#xed;guez</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Neurolog&#xed;a y Neurocirug&#xed;a Dr. Manuel Velasco Su&#xe1;rez, Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe9;rez-Torres</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Neurolog&#xed;a y Neurocirug&#xed;a Dr. Manuel Velasco Su&#xe1;rez, Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delgado-Garc&#xed;a</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Neurolog&#xed;a y Neurocirug&#xed;a Dr. Manuel Velasco Su&#xe1;rez, Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Trejo</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Neurolog&#xed;a y Neurocirug&#xed;a Dr. Manuel Velasco Su&#xe1;rez, Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cervantes-Uribe</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Neurolog&#xed;a y Neurocirug&#xed;a Dr. Manuel Velasco Su&#xe1;rez, Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jorge-de Sar&#xe1;chaga</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Neurolog&#xed;a y Neurocirug&#xed;a Dr. Manuel Velasco Su&#xe1;rez, Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le&#xf3;n-Manr&#xed;quez</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Neurolog&#xed;a y Neurocirug&#xed;a Dr. Manuel Velasco Su&#xe1;rez, Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vargas-Ca&#xf1;as</LastName><ForeName>E S</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Neurolog&#xed;a y Neurocirug&#xed;a Dr. Manuel Velasco Su&#xe1;rez, Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>S&#xed;ndrome de Vulpian-Bernhardt. Frecuencia, caracter&#xed;sticas cl&#xed;nicas y electrofisiol&#xf3;gicas en un centro de atenci&#xf3;n de tercer nivel en M&#xe9;xico.</VernacularTitle></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Rev Neurol</MedlineTA><NlmUniqueID>7706841</NlmUniqueID><ISSNLinking>0210-0010</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055724" MajorTopicYN="N">Electrophysiological Phenomena</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008800" MajorTopicYN="N" Type="Geographic">Mexico</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062606" MajorTopicYN="N">Tertiary Care Centers</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="TITLE" NlmCategory="BACKGROUND">S&#xed;ndrome de Vulpian-Bernhardt. Frecuencia, caracter&#xed;sticas cl&#xed;nicas y electrofisiol&#xf3;gicas en un centro de atenci&#xf3;n de tercer nivel en M&#xe9;xico.</AbstractText><AbstractText Label="UNLABELLED">Introducci&#xf3;n. El s&#xed;ndrome de Vulpian-Bernhardt (SVB) es un fenotipo cl&#xed;nico at&#xed;pico e infrecuente de la esclerosis lateral amiotr&#xf3;fica (ELA) que condiciona un importante retraso diagn&#xf3;stico, por lo que reconocer sus caracter&#xed;sticas cl&#xed;nicas y electrofisiol&#xf3;gicas tiene relevancia. Materiales y m&#xe9;todos. Estudio retrospectivo y transversal. Se revisaron los expedientes cl&#xed;nicos de pacientes con diagn&#xf3;stico de ELA en el per&#xed;odo de enero de 2017 a diciembre de 2019. Se incluyeron los que cumpl&#xed;an criterios para SVB para describir su frecuencia, caracter&#xed;sticas cl&#xed;nicas y electrofisiol&#xf3;gicas. Resultados. Veinte pacientes (15,8%) cumplieron los criterios para el SVB; el 55% eran mujeres; la edad de inicio de los s&#xed;ntomas era de 46,6 &#xb1; 12,9 a&#xf1;os; presentaba tabaquismo el 40%; la mediana de retraso del diagn&#xf3;stico fue de 24 (12-96) meses; la mediana en afectarse un segundo segmento corporal fue de 24 (12-132) meses, que fue el lumbosacro en el 65%; el promedio en la escala Revised Amyotrophic Lateral Sclerosis Functional Rating Scale fue de 27 &#xb1; 7 puntos; el 45% cumpl&#xed;a los criterios de El Escorial para ELA definida en el momento del diagn&#xf3;stico y el 58,8%, los de Awaji. Se cont&#xf3; con 19 estudios de neuroconducci&#xf3;n y 17 electromiogramas, y se encontr&#xf3; una raz&#xf3;n abductor digiti minimi-abductor pollicis brevis (APB/ADM) menos de 0,6 en el 63% (mano dividida). Conclusiones. Existe un retraso importante en el diagn&#xf3;stico de enfermedades de la motoneurona en general y de SVB en particular. Calcular la raz&#xf3;n APB/ADM y aplicar los criterios de Awaji en el estudio de electrofisiolog&#xed;a puede ser de gran ayuda para aumentar la certeza diagn&#xf3;stica en esta entidad cl&#xed;nica.</AbstractText></OtherAbstract></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>28</Day><Hour>5</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33506486</ArticleId><ArticleId IdType="doi">10.33588/rn.7203.2020126</ArticleId><ArticleId IdType="pii">rn2020126</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>